Announcing AustCham Shanghai's Platinum Member 2021: CSL Behring
We are excited to announce CSL Behring as AustCham Shanghai's Platinum Member for 2021.
CSL Behring has been a long-term partner of AustCham Shanghai and a member of the Chamber since 2006. We look forward to working closely with CSL Behring to support the Australian business community in Shanghai and Greater China in the coming year.
About CSL Behring
Source:CSL Behring
CSL Behring is part of CSL Limited, which has more than 27,000 employees and does business in 35+ countries. CSL Behring is a leading biotherapeutics company that develops and delivers innovative specialty plasma-derived and recombinant therapies to treat rare and serious diseases in the following therapeutic areas – immunology, hematology, cardiovascular and metabolic, respiratory, and transplant.
Company Nominee
Harold Chan is the Vice President & General Manager, Commercial Operations of CSL Behring Greater China, managing the company’s commercial operation activities in China, Taiwan and Hong Kong.
Harold joined CSL Behring in 2015 as Commercial Director for China operations overseeing Sales, Marketing, Distribution and Demand Planning. In 2018, Harold was promoted to Executive Director, China Commercial Operations with expanded responsibilities.
Prior to joining CSL Behring, Harold has extensive experience in the pharmaceutical industry in the Asia Pacific region and China. Commenced his career in Finance, Harold has been served in various management positions covering marketing, business development and commercial responsibilities at multinational companies such as MSD, Cephalon and Teva.
Harold received a bachelor's degree in Economics from Monash University Australia and completed his MBA at Warwick University, United Kingdom. Harold is also a Certified Public Accountant since 1996.
